Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 63, 2008 - Issue 6
13
Views
1
CrossRef citations to date
0
Altmetric
Case Report

SIMULTANEOUS OCCURRENCE OF METASTATIC BREAST CANCER, HODGKIN’S DISEASE AND TUBERCULOUS LYMPHADENITIS IN HOMOLATERAL AXILLARY LYMPH NODES – A CASE REPORT

, &
Pages 391-393 | Published online: 09 Jan 2014

REFERENCES

  • Costa L, GaRafrio C, Franca F, deL Giglio A. SimuLtaneous occur-rence of Hodgkin disease and tubercuLosis: report of three cases. South Med J. 2004; 97: 696–8.
  • Tu Lasi N, Raju P, Damodaran V, Radhika T. A spectrum of coexis-tent tubercuLosis and carcinoma in the breast and axiLLary Lymph nodes: report of five cases. Breast 2006; 15:437–9.
  • Pandey U, Naraynan M, Karnik U, Sinha B. Carcinoma metastasis to unexpected synchronous LymphoproLiferative disorder: report of three cases and review of Literature.] Clin Pathol. 2003; 56: 970–1.
  • Etkind P, Du J, Khan A, PiLLitteri J, Wiernik P. Mouse mammary tumor virus-Like ENV gene sequences in human breast tumors and in a Lymphoma of a breast cancer patient. Clin Cancer Res. 2000; 6: 1273–8.
  • MoreLLo K, Wurz G, DeGregorio M. Pharmacokinetics of seLective estrogen receptor moduLators. Clin Pharmacokinet. 2003; 42: 361–72.
  • Sartor CI. Postmastectomy Radiotherapy in Intermediate-risk Patients:The Gray Zone. Curr OncoE Rep. 2006 Jan;8(1):29–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.